Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Hirsutism and acne indicate high androgen levels in women with PCOS, and early treatment can improve symptoms and quality of life.

Hirsutism and acne indicate high androgen levels in women with PCOS, suggesting early treatment can help.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Higher androgen levels do not cause baldness in men.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Men over 50 may experience hormone decline causing various symptoms, and proper management is crucial.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

These ovarian conditions cause high testosterone levels.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.